key: cord-0032194-qynczv0e authors: Cheung, Emmanuel Hei-Lok; Cheung, Jonathan Chun-Hei; Yip, Yu-Yeung title: Beyond failure or success: reflections on the ethical justifications for time-limited trial of intensive care date: 2022-05-26 journal: Intensive Care Med DOI: 10.1007/s00134-022-06752-8 sha: 787cadfa3be6fe95858fc62c46e0734114225143 doc_id: 32194 cord_uid: qynczv0e nan face of the unpredictable clinical course. This does not imply that we would admit patients to the ICU for TLT despite clear signs of medical futility [3] . We believe that survival should not be taken as "success" automatically; for the same reason, one should not insist that death during a TLT "must be considered a failure" [1] . Although death is not a desirable outcome of life-sustaining treatment, it does not necessarily preclude the successful fulfilment of a dignified death. If it is the patient's will to receive a trial of intensive-care treatment before a potential final transition to end-of-life care, TLT respects patient's autonomy that constitutes a fundamental element of perceived dignity. Donaldson's philosophical inquiry into the goals of clinical medicine has reminded us of the importance of humanistic values in caring for patients at risk of imminent death, in which the moral character of compassion and discernment in the virtue ethics tradition [4] are highly relevant. Offering TLT to patients who opt for proportional (albeit invasive) treatment in the context of a shared agreement is coherent with the ethical intuition of a compassionate doctor. Moreover, due to the recent surge in coronavirus disease 2019 (COVID-19) infections in our city, ICU physicians have been bombarded with difficult triage decisions for elderly patients with severe COVID-19 pneumonia and multiple comorbidities. We consider that establishing TLT agreements at the time of ICU triage may serve as an alternative to the dichotomous process of admission with unrestricted life-sustaining treatments versus non-admission. While rationing consideration is beyond the scope of an individualistic assessment of patient's best interests that formed the basis of our discussions in ethical reasoning for TLT, we believe that it is also important to consider the society's collective interests *Correspondence: ehlcheung@connect.hku.hk in optimising utilisation of ICU beds and safeguarding scarce resources in the contingency capacity. Acknowledging the complexity of the decision-making process, a discerning doctor who tries to make both sensitive and sensible judgements would consider thoroughly whether TLT of intensive care is the best option, after weighing the pros and cons from different parties' perspectives delicately to strike a balance. Finally, we recognise that the provision of life-sustaining treatment and transition to end-of-life care are greatly influenced by cultural and societal contexts. In a locality where the general public is less ready to accept palliative care due to previously established social norms and structural limitations of the healthcare system [5] , TLT may act as a bridge to palliative and end-of-life care in an acute care setting when the expected prognosis is poor (e.g., a young patient with motor neurone disease who developed severe pneumonia) but not immediately obvious to the patients or their surrogates, who may hold unrealistically high expectations of survival with intensive-care treatment despite thorough explanation. TLT respects their autonomy, allowing time for them to comprehend the clinical reality of dying and decide on their preferred care pathway. The fact that different societies may have different popular perceptions and acceptance of intensive-care treatment should be acknowledged. Though controversial, we think that TLT may serve as a sensible compromise in this regard. Author contributions EHL, JCH and YY wrote the manuscript. There is no competing interest or funding to declare. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Death during life sustaining treatment must be considered a failure but can be acceptable if the treatment was proportional Raising awareness for timelimited trial discussion upon ICU triage and admission Time-limited trial of intensive care is more than merely life sustaining A virtue ethics approach to moral dilemmas in medicine Quality of palliative and end-of-life care in Hong Kong: perspectives of Healthcare Providers